1) HBV DNA breakthrough
HBV DNA突破
1.
Objective To evaluate the efficacy of adefovir dipivoxil(ADV) on chronic hepatitis B(CHB) patients with HBV DNA breakthrough(>1.
目的观察阿德福韦酯挽救治疗拉米夫定治疗后HBV DNA突破患者的疗效。
2) HBV DNA
HBV-DNA
1.
Study on associations between HBV DNA and Pre-S1 antigen and serum markers of HBV;
HBV-DNA、乙肝前S1抗原与HBV血清标志物相关性的研究
2.
[Methods]The 156 sera which were taken at random from the titer≥1∶8 HBsAg carriers of the health examinees from January to December 2007 were applied to detect the HBV markers by ELISA and test the contents of HBV DNA by florescene quantitative(FQ-PCR)(the positive standard is >1 000 copies/ml).
[方法]对2007年1~12月到山东省潍坊市疾病预防控制中心查体的全体人员采用RPHA检测HBsAg,对HBsAg滴度≥1:8阳性者随机抽取156例取静脉血分2份,用ELISA法检测乙肝病毒血清标志物;用FQ-PCR检测血清HBV-DNA含量,>1000拷贝/ml为阳性。
3.
RNAi was used to restrain the mRNA of La protein, and the levels of HBsAg, HBeAg and HBV DNA secreted by the HepG2.
15细胞中La蛋白基因沉默,观察培养上清液中HBsAg、HBeAg和HBV-DNA含量变化,研究La蛋白与HBV复制、翻译的相关性。
4) HBV-DNA
HBV-DNA阳性
1.
Analysis of the Dynamic Change of ALT in Hepatocarcinoma Patients After Hepatectomy with Expression of HBV-DNA;
HBV-DNA阳性肝癌患者术后动态观察ALT水平变化对病情发展的评估
2.
Objective To study the relationship between the expression levels of the HBV-DNA and the dynamic changes of ALT,AST and GGT in hepatocarcinoma patients after hepatectomy to probe an index so as to predict complications.
目的研究HBV-DNA阳性原发性肝癌患者血清HBV-DNA水平与血清肝酶学水平变化对并发症发生的评估与防治的关系,以期寻找简便指标预测并发症的发生,指导临床实践。
补充资料:[3-(aminosulfonyl)-4-chloro-N-(2.3-dihydro-2-methyl-1H-indol-1-yl)benzamide]
分子式:C16H16ClN3O3S
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
分子量:365.5
CAS号:26807-65-8
性质:暂无
制备方法:暂无
用途:用于轻、中度原发性高血压。
说明:补充资料仅用于学习参考,请勿用于其它任何用途。
参考词条